{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1444.3.174","meta":{"versionId":"6","lastUpdated":"2021-03-11T01:00:38.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.174","version":"20210311","name":"Immunotherapy Administration","status":"active","date":"2021-03-11T01:00:38-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","version":"2021","concept":[{"code":"0540T","display":"Chimeric antigen receptor T-cell (CAR-T) therapy; CAR-T cell administration, autologous"},{"code":"96365","display":"Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour"},{"code":"96366","display":"Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)"},{"code":"96372","display":"Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular"},{"code":"96374","display":"Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug"},{"code":"96401","display":"Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic"},{"code":"96409","display":"Chemotherapy administration; intravenous, push technique, single or initial substance/drug"},{"code":"96413","display":"Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug"},{"code":"96415","display":"Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)"},{"code":"96416","display":"Chemotherapy administration, intravenous infusion technique; initiation of prolonged chemotherapy infusion (more than 8 hours), requiring use of a portable or implantable pump"}]}]}}